With spoon
7mg little site
25mg big site
NSI-189 is a nootropic and neurogenic research chemical derived from nicotinamide and pyrazine created by Neuralstem, Inc. Research into NSI-189 has been heavily funded by the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH)
1g NSI-189 Freebase
Reference:
[1] - https://books.google.es/books?id=LoiECgAAQBAJ&pg=PA843&redir_esc=y#v=onepage&q&f=false
(Page 843)
[2] - Compositions containing neurogenic agents for inhibition of neuron death and inducing proliferation of neural cells are disclosed - https://www.google.com/patents/US8030492
[3] - A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients - http://www.ncbi.nlm.nih.gov/pubmed/26643541
[4] - FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder - http://investor.neuralstem.com/2013-04-22-FDA-Approves-Neuralstem-To-Treat-Final-Cohort-In-NSI-189-Phase-Ib-Trial-In-Major-Depressive-Disorder
[5] - Effects of NSI-189 phosphate, a neurogenic compound, on quantitative electroencephalography (qEEG) in patients with major depressive disorder (MDD) during a phase Ib randomized, double-blind, placebo-controlled, multiple-ascending-dose study - http://www.neuralstem.com/pdf/CiNP_Poster_189.pdf